First humans test new weight drug in early safety trial
NCT ID NCT06352437
Summary
This was the first-ever study in humans of a new drug called BI 3034701. Its main goal was to check the safety and side effects of different doses in healthy men and in people who are overweight or obese. Researchers also measured how the drug moved through the body after being given as an injection under the skin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité Research Organisation GmbH
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.